Vitamin D3 for Life

Live Enlightened

Article

Clinical and Biochemical Criteria Used to Define Vitamin D Deficiency: Study Summary

Previous related pageClinical and Biochemical Criteria Used to Define Vitamin D Deficiency: Full StudyNext related pageDistinguishing Vitamin D Insufficiency from Deficiency and Sufficiency: Full Study
Study at a glance

Why do guidelines define vitamin D deficiency differently?

This article compares how major guidelines define vitamin D deficiency. They generally use blood levels of 25-hydroxyvitamin D, which reflect vitamin D supply from sunlight, food and supplements. However, the guidelines address different populations and health questions. A blood measurement does not directly show every effect of vitamin D in the body.

Why can the same vitamin D result receive different labels?

The US National Academies linked levels below about 30 nmol/L with deficiency risk. UK guidance used below 25 nmol/L for increased risk to bone and muscle health. The 2011 Endocrine Society guideline defined deficiency below 50 nmol/L. Changing the cut-off changes the label even when the person’s blood level stays the same.

What changed in the Endocrine Society’s 2024 vitamin D guideline?

The Endocrine Society’s 2024 prevention guideline found that there was not enough evidence from trials to identify blood levels linked to specific health benefits. It therefore moved away from its older fixed categories and target for the generally healthy populations considered. This finding does not establish an ideal personal blood level.

Why is a vitamin D blood result only part of diagnosing a bone disease?

Nutritional rickets, a bone disease, is diagnosed using medical history, examination, blood tests and X-rays. Calcium intake and how long vitamin D has been low also affect risk. The article finds the strongest agreement about risks at very low levels. Higher cut-offs need to be understood in relation to the population and health question they address.

Read the full article below ↓

Vitamin D deficiency is usually classified using serum 25-hydroxyvitamin D, or 25(OH)D, but major organisations have not adopted one universal numerical definition. Different thresholds reflect different questions about skeletal disease, population requirements, clinical treatment and public-health risk. For the complete evidence analysis, see Clinical and Biochemical Criteria Used to Define Vitamin D Deficiency: Full Study.

Why definitions differ

Serum 25(OH)D is the standard marker of vitamin D status because it reflects vitamin D supply from sunlight, food and supplements. However, a measured level is a biochemical marker rather than a direct measurement of every vitamin D-dependent process. What Vitamin D Levels Represent explains this distinction between circulating status and wider physiology.

National Academies criteria

The National Academies framework associates concentrations below about 30 nmol/L, or 12 ng/mL, with risk of deficiency. Concentrations from 30 to below 50 nmol/L may be inadequate for some people, while at least 50 nmol/L, or 20 ng/mL, was judged sufficient to meet the requirements of nearly all healthy individuals.

This is fundamentally a population-requirement framework. A concentration selected to cover nearly everyone should not be mistaken for a biological switch below which every individual becomes deficient.

UK SACN criteria

UK SACN concluded that the risk of poor musculoskeletal health increases below 25 nmol/L, or 10 ng/mL. UK guidance has consequently used below 25 nmol/L as a marker of low vitamin D status or deficiency risk.

The difference from the National Academies framework illustrates why Vitamin D Thresholds vs Targets must be interpreted according to the purpose for which the number was chosen.

The older and newer Endocrine Society positions

The 2011 Endocrine Society guideline defined deficiency as below 20 ng/mL, or 50 nmol/L, and insufficiency as 21-29 ng/mL. It also promoted a level above 30 ng/mL in treatment contexts.

The 2024 Endocrine Society prevention guideline moved away from those fixed categories for generally healthy populations. Its panel found insufficient clinical-trial evidence to establish outcome-specific 25(OH)D thresholds and no longer endorsed its former universal 30 ng/mL target or specific sufficiency, insufficiency and deficiency concentrations for the populations considered.

Rickets shows why a number is not the whole diagnosis

The Global Consensus on Nutritional Rickets classified below 30 nmol/L as deficient, 30-50 nmol/L as insufficient and above 50 nmol/L as sufficient. However, it also emphasised that nutritional rickets is diagnosed from clinical history, examination, biochemical findings and radiographic confirmation rather than from 25(OH)D alone.

Calcium intake and the duration of low vitamin D status also modify disease risk. This is why a biochemical category cannot always be equated with an individual clinical outcome.

Deficiency and insufficiency are framework-dependent labels

A person can fall into different categories under different guidelines without any change in their actual blood concentration. Vitamin D Insufficiency Explained examines the particularly variable middle category between clear low status and concentrations generally considered adequate.

The practical meaning

The strongest agreement exists at very low concentrations associated with increased risk of defective mineralisation. Greater disagreement appears when higher cut-offs are used to define inadequacy, sufficiency or optimality.

The most accurate interpretation is therefore not “one guideline must be right and the others wrong.” Each threshold should be read in relation to its population, endpoint and purpose. Laboratory categories are useful tools, but they are not universal physiological boundaries.

Primary evidence and guidance

Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. PMID: 21796828. DOI: 10.17226/13050.

Scientific Advisory Committee on Nutrition. Vitamin D and Health. Public Health England; 2016.

Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930. PMID: 21646368. DOI: 10.1210/jc.2011-0385.

Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. PMID: 38828931. DOI: 10.1210/clinem/dgae290.

Munns CF, Shaw N, Kiely M, et al. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol Metab. 2016;101(2):394-415. PMID: 26745253. PMCID: PMC4880117. DOI: 10.1210/jc.2015-2175.

Related reading

Original sources

Source

Dietary Reference Intakes for Calcium and Vitamin D

Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium.

Publication details

Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US); 2011. PMID: 21796828. DOI: 10.17226/13050.

Read more →
Source

Vitamin D and Health

Scientific Advisory Committee on Nutrition.

Publication details

Scientific Advisory Committee on Nutrition. Vitamin D and Health. Public Health England; 2016.

Read more →